Results

Total Results: 744 records

Showing results for "presence".

501. Antiplatelet-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
     September 01, 2013 - We used Egger’s regression-based test37 to assess the presence of small- study effects.37,38 Strength … We caution that this aggregate risk-of-bias rating can be misleading, especially in the presence of … analyses within studies and across studies, there is insufficient information to support or exclude the presence … Patients One study, the ELEVATE-TIMI 56 trial, genotyped patients on chronic clopidogrel therapy for the presence

502. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - T2DM.55 GLP-1 is a naturally occurring incretin hormone that stimulates insulin production in the presence … management in individuals with a body mass index (BMI) 30 kg/m2 or greater, or 27 kg/m2 or greater in the presence

503. Sleep-Apnea Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
     April 01, 2012 - sleep-disordered breathing concluded that compared with participants without obstructive sleep apnea, the presence … status), New-onset hypertension Compared with participants without obstructive sleep apnea, the presence

504. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Low 1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence or presence … 1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence or presence

505. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Low 1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence or presence … 1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence or presence

506. Venous-Ulcers-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
     January 01, 2014 - inserted central catheter We used the standard definition of a chronic venous leg ulcer, which is the presence … We collected data on subgroups of interest (e.g., age, presence of comorbid conditions [diabetes, obesity

507. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - A “gold standard” (i.e., the best available) reference test is often used to determine true disease presence … While diagnostic tests tend to use a separate “gold standard” reference test to determine the true presence

508. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - A “gold standard” (i.e., the best available) reference test is often used to determine true disease presence … While diagnostic tests tend to use a separate “gold standard” reference test to determine the true presence

509. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - effectively prohibited physician-led endoscopy teams from administering propofol and required the presence … evaluate the show rate at the hospital’s Bridge Clinic and map it to patient demographics in terms of presence

510. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
     April 01, 2012 - Thus, the presence of early visual field loss in even one eye is associated with a measurable impact … Those patients identified to be at higher risk for the disease (either due to presence of risk factors

511. Methods-Guidance-Applicability Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
     January 01, 2011 - Eligibility criteria and proportion of screened patients enrolled; presence of comorbidities Large

512. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
     May 01, 2008 - in bathing, dressing, eating, getting in and out of bed or chairs, walking, and using the toilet), presence

513. Methods Guide Atkins (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
     January 01, 2011 - Eligibility criteria and proportion of screened patients enrolled; presence of comorbidities Large

514. Management of Acute Diverticulitis Topic Nomination Disposition (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/acute-diverticulitis-topic-nomination.pdf
     August 13, 2018 - complicated diverticulitis (ACD).5 As opposed to uncomplicated diverticulitis, ACD is characterized by the presence

515. Disposition of Comments Report for Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
     September 10, 2012 - The presence of certification bodies is very well known, as are data about membership criteria, training

516. heart-failure-readmission-protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_research-protocol.pdf
     June 10, 2013 - by using a random-effects model while accounting for variation among studies.44 We will assess the presence

517. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - experience or confidence in treatment, the patient- provider relationship, provider inexperience, the presence

518. Development of a Primary Care Guie for Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol Use With Epic-Based Electronic Health Record Tools: A Pilot Dissemination Project (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-unhealthy-alcohol-use-final.pdf
     September 01, 2018 - Confidence in the practice that implementation won’t require too many additional resources • The presence

519. mHealth for Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
     April 28, 2017 - use the information from the proposed evidence review to facilitate evidence- based change; or the presence

520. Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
     November 01, 2013 - estimates versus 95% confdence intervals (CIs), depending on the studied outcome, width of the CI, and presence